Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 USD | -1.63% | -8.11% | -35.49% |
Financials (USD)
Sales 2024 * | 664M | Sales 2025 * | 803M | Capitalization | 2.12B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -366M | EV / Sales 2024 * | 3.64 x |
Net Debt 2024 * | 292M | Net Debt 2025 * | 451M | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 * |
-5.2
x | P/E ratio 2025 * |
-5.78
x | Employees | 1,774 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.47% |
Latest transcript on Guardant Health, Inc.
1 day | -1.63% | ||
1 week | -8.11% | ||
Current month | -8.16% | ||
1 month | -22.17% | ||
3 months | -35.89% | ||
6 months | -38.64% | ||
Current year | -35.49% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Wiley
FOU | Founder | 48 | 11-12-31 |
AmrAli Talasaz
FOU | Founder | 44 | 11-12-31 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
BRD | Director/Board Member | 62 | 16-11-30 |
Myrtle Potter
BRD | Director/Board Member | 65 | 21-10-14 |
Vijaya Gadde
BRD | Director/Board Member | 49 | 20-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.22% | 0 M€ | 0.00% | - | |
0.64% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 17.45 | -1.63% | 2,146,690 |
24-03-15 | 17.74 | -3.43% | 2,460,239 |
24-03-14 | 18.37 | -3.32% | 2,209,334 |
24-03-13 | 19 | +1.93% | 1,542,613 |
24-03-12 | 18.64 | -1.84% | 1,306,295 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.49% | 2.16B | |
-20.44% | 10.48B | |
+72.57% | 3.89B | |
-6.29% | 2.47B | |
-21.56% | 1.58B | |
+21.53% | 1.02B | |
+5.46% | 845M | |
-17.58% | 525M | |
-35.10% | 470M | |
+10.80% | 257M |